Russia's Pharmstandard receives LSE award
This article was originally published in Scrip
Executive Summary
Pharmstandard, the largest pharmaceutical manufacturer in Russia, has received the best newcomer award from the London Stock Exchange, where the company's global depositary receipts were listed in May 2007. Augment Investments, a firm managing the stakes of Pharmstandard's main shareholders, raised $880 million in an initial public offering at that time.